Innovative Technology Platform Function Oncology's advanced CRISPR-powered functional genomics platform presents a significant opportunity to collaborate with biotech and pharmaceutical companies seeking cutting-edge tools for cancer research and personalized therapies.

Expanding Wellness Portfolio With recent launches like GLP-Squared Injection and NAD+ therapies, there is a clear potential to upsell or bundle these innovative wellness products to health-focused retailers, clinics, and digital health platforms targeting holistic patient care.

Global Distribution Reach Partnerships with distributors like iHerb indicate a strong international market presence, offering opportunities to expand sales to global health and wellness markets, especially among health-conscious consumers and clinics worldwide.

Financial Growth Potential Although still early stage with revenues between 1M and 10M, functional and strategic investments totaling 28 million dollars position the company for accelerated growth and potential partnership opportunities with larger healthcare and biotech firms seeking innovative solutions.

Strategic Networking Participation in industry events like the ROTH Conference indicates proactive engagement with investors and partners, opening doors for collaborations, joint ventures, or licensing deals to accelerate market penetration and product adoption.